CD274 and neoplasm: In addition, a combination of immune checkpoint inhibitors (ICIs), anti-programmed cell death ligand-1 antibodies, and GC treatment has been reported to significantly improve tumor response and survival compared with GC therapy alone in patients with previously untreated, unresectable, or metastatic CCA [11].